Back to top

Decoy Therapeutics’ D-MAV platform shows inhibition of Ebola Zaire virus

Decoy Therapeutics (DCOY) announced that one of its D-MAV candidates demonstrates in vitro activity against wild-type Ebola Zaire virus in testing ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Decoy Therapeutics Inc (DCOY)